Key Takeaways TMO acquired Solventum's unit for $4.1B and Olink to expand biologics and proteomics capabilities. TMO's recent product launches include CorEvitas AA Registry and EVOS S1000 Spatial Imaging System. Thermo Fisher faces ongoing macroeconomic and currency headwinds that may impact profitability.Thermo Fisher Scientific Inc. (TMO) focuses on expanding through the acquisition of technologies and businesses that augment its existing products and services. The company continues to enhance its portf ...

Sally Beauty Holdings, Inc. (SBH) announced mixed results for the second quarter of fiscal 2025. Earnings improved year over year and surpassed the Zacks Consensus Estimate, while revenues declined from the prior-year quarter and fell short of the consensus mark. The revenue shortfall was primarily due to ongoing macroeconomic challenges. In response, management lowered its full-year outlook to better reflect current business conditions.SBH’s Q2 Performance: Key Metrics & InsightsSally Beauty’s adjusted ear ...

Energizer Holdings, Inc. (ENR) reported second-quarter fiscal 2025 results, wherein both net sales and earnings lagged the Zacks Consensus Estimate. Also, the top and bottom lines decreased year over year.The company reported modest growth in its battery segment but faced declines in Auto Care due to shipment timing shifts. Energizer introduced its new Podium Series, which saw widespread distribution across numerous stores. Gross margins improved, aided by cost-saving initiatives, while strategic refinancin ...

Reddit CEO Steve Huffman stands on the floor of the New York Stock Exchange (NYSE) after ringing a bell on the floor setting the share price at $47 in its initial public offering (IPO) on March 21, 2024 in New York City.Reddit reported first-quarter earnings Thursday that beat Wall Street expectations on sales and guidance.Shares of the social media company rose more than 16% in after-hours trading.Here's how the company did compared with LSEG estimates:Earnings per share: 13 cents vs. 2 cents expectedReven ...

STERIS plc’s (STE) Healthcare business continues to benefit from robust U.S. procedure volumes, favorable pricing and market share gains. Service revenues fuel the Applied Sterilization Technologies (“AST”) segment’s growth. Moreover, sound financial health bodes well for the stock. Meanwhile, macroeconomic challenges and adverse currency impacts appear concerning for the company’s operations. In the past year, shares of this Zacks Rank #3 (Hold) company have advanced 10.4% against the industry’s 10.4% fall ...